Last $14.81 USD
Change Today -0.04 / -0.27%
Volume 14.0M
BSX On Other Exchanges
New York
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

300 Boston Scientific Way

Marlborough, MA 01752-1234

United States

Phone: 508-683-4000

Fax: 508-650-8923

such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. In 2013, the company received FDA approval for the IntellaTip MiFi XP catheter, with MicroFidelity sensor technology, representing a new generation of high-resolution ablation catheters for treatment of atrial flutter. In 2012, the company acquired Rhythmia Medical, Inc. (Rhythmia), a developer of mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter. The company received CE Mark approval for the Rhythmia technology during 2013. In 2013, the company acquired the electrophysiology business of C.R. Bard Inc. (Bard EP). MedSurg Endoscopy Gastroenterology The company markets a range of products to diagnose, treat and ease various digestive diseases, including those affecting the esophagus, stomach, liver, pancreas, duodenum, and colon. Common disease states include esophagitis, portal hypertension, peptic ulcers, as well as esophageal, biliary, pancreatic and colonic cancer. The company offers the Radial Jaw 4 Single-Use Biopsy Forceps, which are designed to enable collection of tissue specimens without the need to use large channel therapeutic endoscopes. The company’s line of RX Biliary System devices are designed to provide access and control for physicians to diagnose and treat conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts and obtaining biopsies in suspected tumors. The company also markets the Spyglass Direct Visualization System for direct imaging of the pancreatico-biliary system. The Spyglass System is a single-operator cholangioscopy device that offers clinicians a direct visualization of the pancreatico-biliary system and includes supporting devices for tissue acquisition, stone management and lithotripsy. The company’s products also include the WallFlex family of stents, in particular, the WallFlex Esophageal line and WallFlex Biliary line for treatment of biliary strictures. In addition, within its hemostasis franchise, the company offers its Resolution Clip Device for gastrointestinal bleeding, engineered to enable opening and closing up to five times prior to deployment. Interventional Bronchoscopy The company markets devices to diagnose, treat and ease pulmonary disease systems within the airway and lungs. The company’s products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. The company’s product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. In 2010, the company acquired Asthmatx, Inc., which added to its Endoscopy portfolio a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System has CE Mark, China Food and Drug Administration and U.S. FDA approval and is the device-based asthma treatment approved by the FDA. Urology and Women’s Health The company’s Urology and Women’s Health division develops, manufactures, and sells devices to treat various urological and gynecological disorders. Within its Urology business, the company sells various products designed to treat patients with urinary stone disease and benign prostatic hyperplasia (BPH). The company offers a full line of stone management products, including ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons and catheters. Within its Women's Health business, the company markets a range of devices for the treatment of conditions, such as female urinary incontinence, pelvic floor reconstruction (rebuilding of the anatomy to its original state), and menorrhagia (excessive menstrual bleeding). The company offers mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices. The company markets its Genesys Hydro Therm


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BSX:US $14.81 USD -0.04

BSX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $138.08 USD -2.23
CR Bard Inc $171.03 USD -5.91
Olympus Corp ¥4,120 JPY -15.00
St Jude Medical Inc $65.87 USD -0.47
Terumo Corp ¥2,941 JPY +35.00
View Industry Companies

Industry Analysis


Industry Average

Valuation BSX Industry Range
Price/Earnings 69.1x
Price/Sales 2.7x
Price/Book 2.9x
Price/Cash Flow 27.3x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOSTON SCIENTIFIC CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at